Invest
sanofi
About The Stock
null
27 Years
of legacy
4.4 Star
App Rating
1 Crore +
Customers
Achieve your Investment goals today!
Pharmaceuticals company Sanofi India announced Q2CY23 results:
Managing Director, Sanofi India, said, “The Company has delivered a strong second quarter performance despite the NLEM impact. The Company’s ‘India for India’ strategy reflects Sanofi’s ambition in the Indian Market. The Company will continue to focus on driving further improvement in operating efficiencies while expanding the availability of its established and innovative products in India.”
| CLIENT NAME | DEAL TYPE | ACTION | DATE | AVG. PRICE | QUANTITY | EXCHANGE |
|---|---|---|---|---|---|---|
| ISHARES CORE MSCI EMERGING MARKETS ETF | Block | Purchase | 2022-10-17 | 5743.7 | 38863 | BSE |
| ISHARES MSCI INDIA SMALL-CAP ETF | Block | Purchase | 2022-10-17 | 5743.7 | 4485 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | Block | Sell | 2022-10-17 | 5743.7 | 38863 | BSE |
| Financials( ₹ in Cr) | Sanofi India Ltd | Sun Pharmaceuticals Industries Ltd | Cipla Ltd | Zydus Lifesciences Ltd | Divis Laboratories Ltd |
|---|---|---|---|---|---|
| Price | 8,851.95 | 1,531.40 | 1,399.05 | 1,051.40 | 3,910.75 |
| % Change | 3.21 | -0.32 | -1.55 | 4.20 | -0.52 |
| Mcap ₹ Cr | 20,386.93 | 3,67,434.16 | 1,12,954.68 | 1,05,795.44 | 1,03,818.29 |
| Revenue TTM ₹ Cr | 2,851.10 | 43,885.68 | 22,753.12 | 17,237.40 | 7,767.51 |
| Net Profit TTM ₹ Cr | 602.90 | 8,560.84 | 2,835.49 | 1,997.30 | 1,823.38 |
| PE TTM | 35.84 | 39.15 | 26.62 | 28.83 | 75.36 |
| 1 Year Return | 37.77 | 62.75 | 51.72 | 103.72 | 19.25 |
| ROCE | 70.62 | 16.79 | 17.79 | 16.25 | 19.30 |
| ROE | 52.65 | 16.46 | 12.82 | 14.05 | 14.89 |
Equity Capital: 1,015.20 Cr FV: 10.00
| Period | MF Net Purchase / (sold) | FII Net |
|---|---|---|
| LAST 1M | 44,248.95 | -31,659.16 |
| LAST 3M | 1,05,886.10 | -43,482.14 |
| LAST 6M | 1,73,149.22 | 48,654.40 |
| LAST 12M | 2,64,707.07 | 1,27,969.33 |
| Date | Action Type | Ratio |
|---|---|---|
| May 03, 2024 | Dividend | 1170 |
| Mar 07, 2024 | Dividend | 500 |
| Apr 28, 2023 | Dividend | 1830 |
Sanofi Hse 117-B Saki Vihar Rd, L&T Business Park Powai, Mumbai, Maharashtra, 400072
| Tel | : | 91-22-28032000 |
| : | igrc.sil:sanofi.com | |
| Website | : | http://www.sanofiindialtd.com |
Link Intime India Pvt Ltd
| AGM Date (Month) | : | May |
| Face Value Equity Shares | : | 10 |
| Market Lot Equity Shares | : | 1 |
| BSE Code | : | 500674 |
| NSE Code | : | SANOFI |
| Book Closure Date (Month) | : | Apr/May |
| BSE Group | : | A |
| ISIN | : | INE058A01010 |
FAQ’s on Sanofi India Ltd SharesYou can buy Sanofi India Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Sanofi India Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 17, 2024 03:59 PM the closing price of Sanofi India Ltd was Rs.8,851.95.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of May 17, 2024 03:59 PM, the market cap of Sanofi India Ltd stood at Rs. 20,386.93.
The latest PE ratio of Sanofi India Ltd as of May 17, 2024 03:59 PM is 35.84
The latest PB ratio of Sanofi India Ltd as of May 17, 2024 03:59 PM is 0.05
The 52-week high of Sanofi India Ltd share price is Rs. 9,380.00 while the 52-week low is Rs. 6,256.60
According to analyst recommendations, Sanofi India Ltd Share has a "Buy" rating for the long term.
Achieve your Investment goals today!
